s6y

MUSTANG BIO, INC.

Ticker
MBIO
CIK
1680048
Industry
Pharmaceutical Preparations

Financials 42

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 42 financials filings

News 112

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 112 news filings

Ownership 96

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. SC 13G/A Major Shareholders

All 96 ownership filings

Prospectus 46

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1 General form of registration statement for all companies including face-amount certificate companies
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. S-3 Registration statement for specified transactions by certain issuers

All 46 prospectus filings

Proxies 32

  1. DEF 14A Definitive proxy statements
  2. DEF 14C Definitive information statements
  3. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  4. DEF 14C Definitive information statements
  5. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  6. DEF 14A Definitive proxy statements
  7. DEF 14C Definitive information statements
  8. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 32 proxies filings

Other 77

  1. SCHEDULE 13D/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13G/A
  4. SCHEDULE 13G/A
  5. SCHEDULE 13G/A
  6. EFFECT Notice of Effectiveness
  7. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  8. SCHEDULE 13D/A
  9. POS EX Post-effective amendment filed solely to add exhibits to a registration statement
  10. SCHEDULE 13G

All 77 other filings